CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $330,000 | +41.0% | 23,683 | +4.1% | 0.13% | +104.8% |
| Q4 2016 | $234,000 | +21.2% | 22,749 | +19.1% | 0.06% | +37.0% |
| Q3 2016 | $193,000 | -6.8% | 19,100 | +3.6% | 0.05% | +21.1% |
| Q2 2016 | $207,000 | -88.6% | 18,444 | -86.2% | 0.04% | -85.5% |
| Q1 2016 | $1,819,000 | -7.9% | 133,184 | +27.9% | 0.26% | +23.0% |
| Q4 2015 | $1,975,000 | -72.5% | 104,134 | -72.8% | 0.21% | -69.2% |
| Q3 2015 | $7,174,000 | +835.3% | 382,196 | +641.7% | 0.69% | +822.7% |
| Q2 2015 | $767,000 | +43.1% | 51,527 | +45.6% | 0.08% | +41.5% |
| Q1 2015 | $536,000 | -67.7% | 35,398 | -71.6% | 0.05% | -66.5% |
| Q4 2014 | $1,658,000 | +445.4% | 124,502 | +416.6% | 0.16% | +507.7% |
| Q3 2014 | $304,000 | +86.5% | 24,098 | +49.0% | 0.03% | +100.0% |
| Q2 2014 | $163,000 | – | 16,177 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |